Mixed fortunes for Getty Images, TherapeuticsMD, and Solid Biosciences

  • Getty Images lowers 2023 outlook, shares drop 5.8%
  • TherapeuticsMD explores strategic alternatives, shares rise 4.5%
  • Solid Biosciences’ gene therapy candidate gets FDA clearance, shares surge 40%

Getty Images Holdings has revised its 2023 outlook downwards due to various challenges, including strikes in Hollywood and a stronger dollar. As a result, the company’s shares dropped by 5.8% in after-market trading. Meanwhile, TherapeuticsMD, a pharmaceutical royalties owner, has announced that it will explore strategic alternatives such as acquisitions, mergers, or asset sales. This news has caused the company’s shares to rise by 4.5% in post-market trading. In other news, Solid Biosciences has received clearance from the Food and Drug Administration for its investigational new drug application for a Duchenne Muscular Dystrophy gene therapy candidate. This development has led to a significant surge of 40% in the company’s shares in after-market trading.

Factuality Level: 7
Factuality Justification: The article provides factual information about the lowered outlook of Getty Images Holdings, the consideration of strategic alternatives by TherapeuticsMD, and the clearance of Solid Biosciences’ drug application by the FDA. However, it lacks context and details about the strikes in Hollywood and the impact of a stronger dollar on Getty Images Holdings. Additionally, it does not provide any analysis or expert opinions, making it a relatively straightforward news report.
Noise Level: 3
Noise Justification: The article provides brief updates on various companies and their stock performance, but lacks in-depth analysis or evidence to support the claims. It also does not provide any actionable insights or solutions for the reader.
Financial Relevance: Yes
Financial Markets Impacted: Getty Images Holdings, TherapeuticsMD, Solid Biosciences
Presence Of Extreme Event: No
Nature Of Extreme Event: No
Impact Rating Of The Extreme Event: No
Rating Justification: The article discusses financial updates and developments in various companies, but there is no mention of any extreme events or their impacts.
Public Companies: Getty Images Holdings (N/A), TherapeuticsMD (N/A), Solid Biosciences (N/A)
Key People:

Reported publicly: www.marketwatch.com